Chronic pain biotech co-founded by Vivek Ramaswamy joins reverse merger train

Ambros Therapeutics will take the Nasdaq spot of Werewolf Therapeutics, a cancer biotech that has been exploring strategic alternatives for most of this year, the companies said Friday morning.

Raccontata daendpoints.news